| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| FibroBiologics, Inc. | General Counsel | Common Stock | 180,000 | $58,752 | $0.3264 | 27 Feb 2026 | Direct |
| FibroBiologics, Inc. | General Counsel | Stock Option (Right to Buy) | 189,000 | 26 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FBLG | FibroBiologics, Inc. | 27 Feb 2026 | 1 | +$13,056 | 4 | General Counsel | 02 Mar 2026, 09:15 |
| FBLG | FibroBiologics, Inc. | 11 Dec 2025 | 1 | +$47,600 | 4 | General Counsel | 12 Dec 2025, 07:16 |
| FBLG | FibroBiologics, Inc. | 26 Mar 2025 | 1 | $0 | 4 | General Counsel | 28 Mar 2025, 16:10 |
| FBLG | FibroBiologics, Inc. | 27 Dec 2024 | 1 | $0 | 4 | General Counsel | 30 Dec 2024, 16:18 |
| FBLG | FibroBiologics, Inc. | 01 Mar 2024 | 1 | $0 | 4 | General Counsel | 08 Mar 2024, 16:14 |
| FBLG | FibroBiologics, Inc. | 01 Mar 2024 | 0 | $0 | 3 | General Counsel | 06 Mar 2024, 16:05 |